Skip to main content
SpringerLink
Log in

Anticoagulants, Fibrinolytics, and Hemostatics

  • Chapter
Pharmacology of the Eye

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 69))

  • 371 Accesses

Abstract

Anticoagulants, fibrinolytics, and hemostatics are substances which interfere with the mechanism of hemostasis. Hemostasis is the spontaneous cessation of bleeding from a damaged vessel. The mechanism of hemostasis is summarized in Fig. 1. As is apparent from the figure, three main processes are involved:

  1. 1.

    Adhesion and aggregation of platelets (primary hemostasis)

  2. 2.

    Blood coagulation

  3. 3.

    Fibrinolysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Algan B, Leyder C, Marchal H, Geoffroy D, Marquis A (1976) Considerations sur l’étiologie des thromboses veneuses rétiniennes. Bull Soc Beige Ophtalmol 172:631–636

    CAS  Google Scholar 

  • Alkjaersig N, Fletcher AP, Sherry S (1959) The mechanism of clot dissolution by plasmin. J Clin Invest 38:1086–1095

    Article  PubMed  CAS  Google Scholar 

  • Ambrus CM, Markus G (1960) Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme. Am J Physiol 199:491–494

    PubMed  CAS  Google Scholar 

  • Andersson L, Eriksson O, Hedlund PO, Kjellman H, Lindquist B (1978) Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. Urol Res 6:83–88

    PubMed  CAS  Google Scholar 

  • Bramsen T (1976) Traumatic hyphaema treated with the antiflbrinolytic drug tranexamic acid. I. Acta Ophthalmol 54:250–256

    CAS  Google Scholar 

  • Bramsen T (1977) Traumatic hyphaema treated with the antiflbrinolytic drug tranexamic acid. II. Acta Ophthalmol 55:616–620

    CAS  Google Scholar 

  • Bramsen T (1979) Fibrinolysis and traumatic hyphaema. Acta Ophthalmol 57:447–454

    CAS  Google Scholar 

  • Chapman Smith JS, Crock GW (1977) Urokinase in the treatment of vitreous haemorrhages. Br J Ophthalmol 61:500–505

    Article  PubMed  CAS  Google Scholar 

  • Cleary AE, Davies EWG, Shilling JS, Hamilton AM (1974) Intravitreal urokinase in the treatment of vitreous haemorrhages. Trans Ophthalmol Soc UK 94:587–590

    PubMed  CAS  Google Scholar 

  • Crouch ER, Frenkel M (1976) Aminocaproic acid in the treatment of traumatic hyphema. Am J Ophthal 81:355–360

    PubMed  Google Scholar 

  • Den Ottolander GJH, Craandijk A (1968) Treatment of thrombosis of the central retinal vein with streptokinase. Thrombos Diathes Haemorrh 20:415–419

    Google Scholar 

  • Denson KWE, Bonnar J (1975) Measurement of heparin in patients receiving subcutaneous heparin therapy. Br J Haemat 30:139–144

    Article  CAS  Google Scholar 

  • Dugmore WN, Raichand M (1973) Intra vitreal urokinase in the treatment of vitreous haemorrhage. Am J Ophthalmol 75:779–781

    PubMed  CAS  Google Scholar 

  • Fodstad H, Liljequist B, Schannong M, Thulin CA (1978) Tranexamic acid in the preoperative management of ruptured intracranial anueurysm. Surg Neurol 10:9–15

    PubMed  CAS  Google Scholar 

  • Forrester J, Williamson J (1973) Resolution of intra vitreal clots by urokinase. Lancet 11:197–181

    Google Scholar 

  • Forrester J, Lee WL, Williamson J (1978) The pathology of vitreous haemorrhages. Arch Ophthalmol 96:703–710

    Article  PubMed  CAS  Google Scholar 

  • Gelmers HJ (1980) Prevention of recurrence of spontaneous subrachnoidal haemorrhage by tranexamic acid. Acta Neurochir 52:45–50

    Article  CAS  Google Scholar 

  • Hamburger FA (1970) Netzhautblutungen in beiden Augen nach Therapie mit Antikoagulantien. Wien Klin Wschr 82:549

    Google Scholar 

  • Holmberg L, Bladh B, Aastedt B (1976) Purification of urokinase by affinity chromatography. Biochim Biophys Acta 445:215–222

    PubMed  CAS  Google Scholar 

  • Holmes Sellors PJ, Kanski JJ, Watson DM (1974) Intra vitreal urokinase in the management of vitreous haemorrhages. Trans Ophthalmol Soc UK 94:591–596

    Google Scholar 

  • Howden GD (1959) The successful treatment of a case of central retinal vein thrombosis with intravenous fibrinolysin. Can Med Assoc J 80:382–384

    Google Scholar 

  • Jakobsson KG, Lindahl U (1979) Attempted determination of endogenous heparin in blood. Abstract 0195. Seventh international congress on thrombosis and haemostasis, London

    Google Scholar 

  • Jerndal T, Frisen M (1976) Tranexamic acid (AMCA) and late hyphaema. A double blind study in cataract surgery. Acta Ophthalmol 54:417–429

    CAS  Google Scholar 

  • Kakkar VV: Deep venous thrombosis; detection and prevention. Circulation 51:8–19

    Google Scholar 

  • Khoner EM, Petit JE, Hamilton AM, Bulpit CJ, Dollery CT (1976) Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J I:550–553

    Article  Google Scholar 

  • Kluft O, Stortenbeck W, De Vries SI, Wieberdink J (1965) The postoperative dip in peroperative anticoagulation. Thrombos Diathes Haemorrh 13:218–234

    CAS  Google Scholar 

  • Kwaan HC, Dobbie JG, Fetkenhour CL (1977) The use of anticoagulants and thrombolytic agents in occlusive retinal vascular diseases. In: Paoletti R, Sherry S (eds) Thrombosis and urokinase. Academic, New York, pp 191–198

    Google Scholar 

  • Neumann L (1976) Les hemorragies conjonctivales, retiniennes et vitreennes au cours des traitements anticoagulants de longue duree. Bull Soc Franc Ophtal 86:164–166

    Google Scholar 

  • Nilsson IM (1974) Haemorrhagic and thrombotic disorders. Wiley, London

    Google Scholar 

  • Oesterlind G, Nilsson IM (1968) Extraction of cataract in a patient with severe haemophilia. Acta Ophthalmol 42:176–181

    Google Scholar 

  • Oehrstrom A (1972) Treatment of traumatic hyphaema with corticosteroids and mydriatics. Acta Ophthalmol 50:549–555

    Google Scholar 

  • Pandolfi M (1978) Intraocular haemorrhages. A haemostatic therapeutic approach. Surv Ophthalmol 22:322–334

    Article  PubMed  CAS  Google Scholar 

  • Pandolfi M (1979) Haemorrhages in ophthalmology. Thieme, Stuttgart

    Google Scholar 

  • Pandolfi M, Lantz E (1979) Partial purification and characterization of keratokinase, the fibrinolytic activator of the cornea. Exp Eye Res 29:563–571

    Article  PubMed  CAS  Google Scholar 

  • Pierse D, Le Grice H (1964) The use of urokinase in the anterior chamber of the eye. J Clin Path 17:362

    Article  PubMed  CAS  Google Scholar 

  • Rabinowics IM, Litman S, Michaelson IC (1968) Branch venous thrombosis. A pathological report. Trans Ophthalmol Soc UK 88:191–210

    Google Scholar 

  • Rakusin W (1972) Urokinase in the management of traumatic hyphaema. Br J Ophthalmol 55:826–832

    Article  Google Scholar 

  • Sears ML (1970) Surgical management of black ball hyphema. Trans Am Acad Ophth Otol 74:820–827

    CAS  Google Scholar 

  • Seitz R (1964) The retinal vessels. Mosby, St. Louis, p 74

    Google Scholar 

  • Vannas S, Raitta C (1966) Anticoagulant treatment of retinal venous occlusion. Am J Ophthalmol 62:874–884

    PubMed  CAS  Google Scholar 

  • Vassalli JD, Hamilton J, Reich E (1976) Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors and cyclic nucleotides. Cell 8:271–281

    Article  PubMed  CAS  Google Scholar 

  • Varnek L, Daalsgard C, Hansen A, Klie F (1980) The effect of tranexamic acid on secondary haemorrhage after traumatic hyphaema. Acta Ophthalmol 58:787

    CAS  Google Scholar 

  • Yin ET, Wessler S, Stoll PJ (1971) Biological properties of the naturally occurring plasma inhibitors to the activated factor X. J Biol Chem 246:3703–3711

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. Pandolfi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology and Visual Science, School of Medicine, Yale University, 333 Cedar Street, New Haven, CT, 06510, USA

    Marvin L. Sears

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pandolfi, M. (1984). Anticoagulants, Fibrinolytics, and Hemostatics. In: Sears, M.L. (eds) Pharmacology of the Eye. Handbook of Experimental Pharmacology, vol 69. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69222-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69222-2_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69224-6

  • Online ISBN: 978-3-642-69222-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation